Cognizin citicoline enters neuromuscular research as Kirin reports early cell-model findings
Kirin’s Cognizin citicoline improved neuromuscular junction markers in cell models, opening a new research path that still needs human trials.
Kirin’s Cognizin citicoline improved neuromuscular junction markers in cell models, opening a new research path that still needs human trials.
Kyowa Hakko's Eyemuse postbiotic enters children's gummies with Zen Nutrients. We analyse the clinical evidence, regulatory gaps, and market implications. Read more.